[Linezolid as alternative treatment for vascular prosthesis infections].
Martínez-Ramos
David
D
Molina-Martínez
Jorge
J
Villalba-Munera
Vicente
V
Salvador-Sanchís
José Luis
JL
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001012:Aorta, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013396:Suction; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D008795:Metronidazole; D002442:Ceftazidime; D000069349:Linezolid